allowing clinical staff around the world to calculate patients’ probability of
developing critical illness within 5, 10 and 30 days using 10 clinical variables.
While its immediate focus is on COVID-19, the lab’s long-term mission, in its own words, is to “utilize big data and AI for the screening, prevention and control, and warning of outbreaks, respiratory diseases and thoracic diseases.”
Desde Nicaragua
Clínica de Asma y Alergia
Dr. Juan Herrera Salazar.
+5 8882 5513 , + 5 8431 6459
No hay comentarios:
Publicar un comentario